European Archives - Page 398 of 1103 - European Medical Journal

Spotlight: January-April 2023

GOLD looks back at some of the top news stories from the pharmaceutical industry over the last few months, covering landmark therapy approvals, insulin price cuts and much more.

Interview: Nancy Reau

My father always wanted me to be a doctor. He was a police officer and would come home late at night, talking about forensics and autopsies. My best friend in grade school had doctors for parents: a neurologist and neurosurgeon.

Unlocking pharma's creative juices

Explore the benefits of using agencies in pharma marketing and some of the reasons why creativity needs to be brought to the foreground.

Fighting Inequality: Pioneering Research in Endometriosis

This episode focuses on endometriosis and discusses current and new innovative ways for diagnosing this condition.

Interview: Thomas Huizinga

Since I was in high school I have always found these topics very interesting. But I was also very interested in pathogenesis and wanted to know how biology works.

Interview: Katherine P. (Kathy) Andriole

Through my engineering work, I was particularly interested in signal processing, and signals in computers are really just ones and zeros that you can manipulate mathematically.

EMJ Radiology 4.1 2023

Welcome to the latest issue of EMJ Radiology! We are proud to share with you research, case reports, and features that highlight key topics in the field.

Radiographers at the European Congress of Radiology (ECR 2023)

The 2023 European Congress of Radiology (ECR), with its ‘Cycle of Life’ theme, returned to Vienna, Austria, at its traditional time in March. There were over 1,000 radiographers registered, and the Radiographers’ Scientific Sub-Committee, expertly led by Nejc Mekiš and Kevin O’Regan, had prepared an excellent selection of 35 radiographer-focused sessions.

Interventional Treatment in Small-Sized Hepatocellular Carcinoma Using Microwave Ablation: Evaluation of Local Response and Survival

To retrospectively evaluate the safety and efficacy of CT-guided percutaneous microwave ablation (MWA) of small-sized (≤2 cm) hepatocellular carcinoma (HCC) regarding therapy response and survival rates. The goal is to compare data from minimal invasive treatments like MWA and radiofrequency ablation in comparison to surgical resection or data from liver transplantation.

Retrospective Single Centre Study to Evaluate the Use of Targeted Radiofrequency Ablation Followed by Vertebroplasty in Difficult-to-Reach Metastatic Spinal Lesions

The high incidence of bone metastases, particularly vertebral metastases, in patients with cancer and the limitations of conventional treatments are the main challenge for the interventional oncology specialty.